CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy injection before surgery shows promise for skin cancer
Disease control CompletedThis early-phase study tested an experimental immunotherapy drug, cemiplimab, given as injections directly into skin tumors before surgery. The goal was to see if the drug is safe and how well it shrinks or eliminates the cancer. The study included 97 people with two common types…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
Real-World study confirms Cemiplimab's effectiveness for advanced skin cancer
Disease control CompletedThis study followed 287 people with advanced skin cancer (squamous cell or basal cell) who were treated with cemiplimab in everyday medical practice. Researchers measured how well the drug shrank tumors, how long the effects lasted, and any side effects. The goal was to see if re…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:01 UTC
-
New combo therapy shows promise in advanced skin and uterine cancers
Disease control CompletedThis study tested a new drug combination (MK-4280A) in 163 people with either a type of skin cancer (cutaneous squamous cell carcinoma) or endometrial cancer. The goal was to see if the treatment could shrink or eliminate tumors. Participants received either the new combination o…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Drug shrinks skin cancer before surgery in early trial
Disease control CompletedThis study tested the drug cemiplimab given before surgery for people with stage II to IV skin cancer (cutaneous squamous cell carcinoma). The main goal was to see if the drug could make the cancer disappear completely by the time of surgery. 79 participants received cemiplimab b…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New drug combo shows promise for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had come back or spread. The goal was to see if the combo could shrink tumors or slow the disease. Participants were grouped based on whether they had r…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
New study explores the hidden struggles of head and neck skin cancer patients
Knowledge-focused CompletedThis study looked at how people with a serious type of skin cancer on the head or neck feel about their treatment choices, their quality of life, and their care. Researchers asked 78 patients to fill out questionnaires. The goal was to learn more about their experiences, not to t…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC